Prior notification of a concentration (Case M.11447 – BRIDGEPOINT / NEXITY LAMY AND ORALIA PARTENAIRES) – Candidate case for simplified procedure
Date: 2024-02-06
Institutions: Directorate-General for Competition, European Commission
Subjects: economic concentration, insurance occupation, investment company, merger control, property insurance, real estate business, real property, service, subsidiary








C_202401353EN.000101.fmx.xml












Official Journal of the European Union


EN
Series C













C/2024/1353


6.2.2024






Prior notification of a concentration
(Case M.11447 – BRIDGEPOINT / NEXITY LAMY AND ORALIA PARTENAIRES)
Candidate case for simplified procedure
(Text with EEA relevance)
(C/2024/1353)


1.   
On 26 January 2024, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


Bridgepoint Group plc (‘Bridgepoint’) of United Kingdom,










—


Nexity Lamy and Oralia Partenaires, wholly owned and controlled by Nexity SA, all of France.




Bridgepoint will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Nexity Lamy and Oralia Partenaires.
The concentration is accomplished by way of purchase of shares.


2.   
The business activities of the undertakings concerned are the following:






—


Bridgepoint is active in private asset growth investing across private equity and private debt, focusing on middle market businesses across four verticals: (i) Advanced Industrials, (ii) Business & Financial Services, (iii) Consumer and (iv) Healthcare.










—


Nexity Lamy and Oralia Partenaires are two wholly-owned subsidiaries of Nexity SA, operating in real estate services and real estate insurance brokerage services in France.






3.   
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
Pursuant to the Commission Notice on a simplified treatment for certain concentrations under Council Regulation (EC) No 139/2004 on the control of concentrations between undertakings (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.


4.   
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.11447 – BRIDGEPOINT / NEXITY LAMY AND ORALIA PARTENAIRES
Observations can be sent to the Commission by email or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  
            OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  
            OJ C 160, 5.5.2023, p. 1.


ELI: http://data.europa.eu/eli/C/2024/1353/oj
ISSN 1977-091X (electronic edition)